Kenneth J. Hillan's Net Worth
$449 Thousand
Who is Kenneth J. Hillan?
Kenneth J. Hillan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Relypsa Inc, SANGAMO THERAPEUTICS, INC, Zymeworks Inc., 23andMe Holding Co., Zymeworks Inc., and Achaogen Inc.
SEC CIK
Kenneth J. Hillan's CIK is 0001600359
Past Insider Trading and Trends
2022 was Kenneth J. Hillan's most active year for acquiring shares with 5 total transactions. Kenneth J. Hillan's most active month to acquire stocks was the month of May. 2016 was Kenneth J. Hillan's most active year for disposing of shares, totalling 6 transactions. Kenneth J. Hillan's most active month to dispose stocks was the month of August. 2022 saw Kenneth J. Hillan paying a total of $0.00 for 748,004 shares, this is the most they've acquired in one year. In 2016 Kenneth J. Hillan cashed out on 25,500 shares for a total of $131,146.55, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Relypsa Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.49K |
$32.00 | -$111,584.00 |
0
|
Sep 1
| |||
Form 4
| +181.89% | 2.25K |
—
|
—
| 3.49K |
Jun 21
| |||
Form 4
| -45.02% | -1.01K |
$19.31 | -$19,562.55 | 1.24K |
Jun 7
| |||
Form 4
|
∞
| 2.25K |
—
|
—
| 2.25K |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SANGAMO THERAPEUTICS, INC (SGMO) Snapshot price: $0.4842
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +38.94% | 13.9K |
—
|
—
| 49.6K |
Jun 1
| |||
Form 4
| +53.88% | 12.5K |
—
|
—
| 35.7K |
Feb 25
| |||
Form 4
| +54.67% | 8.2K |
—
|
—
| 23.2K |
Feb 25
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Sep 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zymeworks Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
23andMe Holding Co. (ME) Snapshot price: $0.73605
Chief Therapeutics Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +15.06% | 29.03K |
$2.08 | -$31,921.76 | 221.88K |
Jun 5
| |||
Form 4
| -2.34% | -4.63K |
$1.94 | -$8,978.32 | 192.84K |
May 20
| |||
Form 4
| -2.77% | -5.46K |
$2.87 | -$15,661.59 | 191.71K |
Feb 20
| |||
Form 4
| -2.29% | -4.63K |
$2.99 | -$13,837.72 | 197.16K |
Nov 20
| |||
Form 4
| -4.27% | -8.75K |
$3.64 | -$31,860.92 | 196.08K |
Aug 24
| |||
Form 4
| -2.21% | -4.63K |
$3.33 | -$15,411.24 | 204.84K |
Aug 20
| |||
Form 4
| -2.16% | -4.63K |
$2.82 | -$13,048.14 | 209.46K |
Jun 1
| |||
Form 4
|
∞
| 214.09K |
—
|
—
| 214.09K |
Feb 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zymeworks Inc. (ZYME) Snapshot price: $11.32
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
| No matching records found | |||||||||